 |
1mfaH01 |
93.36 |
|
2.60.40.10 |
97 |
62 |
88 |
0.75 |
0.85 |
 |
2vxtH01 |
93.03 |
|
2.60.40.10 |
113 |
63 |
88 |
1.00 |
1.13 |
 |
1mjuH01 |
92.93 |
|
2.60.40.10 |
115 |
70 |
89 |
1.26 |
1.41 |
 |
2q8bH01 |
91.71 |
|
2.60.40.10 |
112 |
58 |
88 |
0.99 |
1.12 |
 |
1yc7A00 |
89.62 |
|
2.60.40.10 |
116 |
33 |
90 |
2.65 |
2.93 |
 |
3d9aH01 |
89.39 |
|
2.60.40.10 |
112 |
34 |
89 |
1.42 |
1.59 |
 |
1t2jA00 |
88.56 |
Homo sapiensSingle chain Fv |
2.60.40.10 |
116 |
43 |
88 |
1.79 |
2.02 |
 |
1ncwH01 |
88.13 |
|
2.60.40.10 |
119 |
38 |
88 |
1.73 |
1.96 |
 |
2otuA00 |
88.04 |
|
2.60.40.10 |
115 |
19 |
88 |
2.84 |
3.20 |
 |
1hxmB01 |
87.82 |
Homo sapiensT-cell receptor gamma-2 chain C region |
2.60.40.10 |
125 |
20 |
84 |
3.03 |
3.61 |
 |
1pewA00 |
87.20 |
Ig lambda chain V-VI region SUTHomo sapiens |
2.60.40.10 |
108 |
21 |
87 |
2.08 |
2.36 |
 |
1kgcE01 |
87.07 |
T-cell receptor beta-1 chain C regionHomo sapiensProtein binding |
2.60.40.10 |
112 |
23 |
88 |
2.36 |
2.67 |
 |
1x9qA01 |
86.97 |
|
2.60.40.10 |
111 |
18 |
85 |
2.16 |
2.52 |
 |
1ogaD01 |
86.85 |
Homo sapiensT-cell receptor alpha chain C region |
2.60.40.10 |
109 |
18 |
88 |
2.79 |
3.17 |
 |
2ak4D01 |
86.76 |
Homo sapiensT-cell receptor alpha chain C region |
2.60.40.10 |
114 |
23 |
88 |
2.87 |
3.24 |
 |
1hzhH01 |
86.68 |
|
2.60.40.10 |
119 |
41 |
72 |
1.13 |
1.56 |
 |
2q20A00 |
86.67 |
|
2.60.40.10 |
105 |
20 |
87 |
2.24 |
2.55 |
 |
1ogaE01 |
86.66 |
T-cell receptor beta-1 chain C regionHomo sapiensProtein binding |
2.60.40.10 |
111 |
23 |
89 |
2.15 |
2.41 |
 |
2ialA01 |
86.44 |
Homo sapiensT-cell receptor alpha chain C region |
2.60.40.10 |
108 |
20 |
87 |
2.88 |
3.27 |
 |
1tvdA00 |
86.44 |
Homo sapiensHDV103S1 |
2.60.40.10 |
116 |
17 |
88 |
2.24 |
2.52 |
 |
2hp4A00 |
86.35 |
T-cell surface glycoprotein CD8 alpha chainCD8A antigen, alpha polypeptideHematopoietic cell lineagePrimary immunodeficiencyHomo sapiens |
2.60.40.10 |
112 |
12 |
85 |
2.06 |
2.40 |
 |
1nezH00 |
86.34 |
T-cell surface glycoprotein CD8 alpha chainProtein homodimerization activityHematopoietic cell lineageCD8A antigen, alpha polypeptideT cell receptor signaling pathway |
2.60.40.10 |
120 |
14 |
83 |
2.18 |
2.62 |
 |
2ij0C00 |
86.30 |
Homo sapiensT cell receptor beta variable 20/OR9-2 |
2.60.40.10 |
118 |
20 |
86 |
1.98 |
2.29 |
 |
1oaqL00 |
86.24 |
|
2.60.40.10 |
110 |
18 |
87 |
2.22 |
2.54 |
 |
1mjuL01 |
86.24 |
|
2.60.40.10 |
113 |
21 |
84 |
2.29 |
2.72 |
 |
1u3hA00 |
86.13 |
Mus musculusTRAV14-3 |
2.60.40.10 |
110 |
22 |
89 |
2.37 |
2.66 |
 |
2nw2A01 |
86.12 |
TRA@ proteinHomo sapiens |
2.60.40.10 |
103 |
19 |
85 |
2.49 |
2.90 |
 |
1kgcD01 |
86.01 |
Homo sapiensT-cell receptor alpha chain C region |
2.60.40.10 |
111 |
17 |
88 |
2.37 |
2.68 |
 |
3bp6A00 |
85.92 |
Mus musculusExternal side of plasma membraneProgrammed cell death protein 1Programmed cell death protein 1T cell receptor signaling pathway |
2.60.40.10 |
111 |
16 |
90 |
2.95 |
3.24 |
 |
1hxmA01 |
85.78 |
|
2.60.40.10 |
121 |
19 |
83 |
2.66 |
3.19 |
 |
2aepL01 |
85.67 |
|
2.60.40.10 |
119 |
17 |
78 |
2.22 |
2.81 |
 |
2p45B00 |
85.39 |
|
2.60.40.10 |
116 |
33 |
87 |
2.45 |
2.81 |
 |
1smoB00 |
84.94 |
Receptor activityTriggering receptor expressed on myeloid cells 1Homo sapiensHumoral immune response |
2.60.40.10 |
110 |
16 |
87 |
2.77 |
3.17 |
 |
2q87C00 |
84.85 |
Homo sapiensCMRF35-like molecule 8CD300 antigen |
2.60.40.10 |
106 |
13 |
89 |
3.84 |
4.28 |
 |
1lp9E01 |
84.84 |
|
2.60.40.10 |
113 |
21 |
87 |
3.02 |
3.45 |
 |
2v44A01 |
84.77 |
Prion diseasesNeural cell adhesion moleculeNeuron cell-cell adhesionPlasma membraneNeural cell adhesion molecule 2 |
2.60.40.10 |
94 |
11 |
76 |
2.11 |
2.76 |
 |
1neuA00 |
84.65 |
Rattus norvegicusMyelin protein P0 |
2.60.40.10 |
115 |
14 |
86 |
2.25 |
2.61 |
 |
2bk8A00 |
84.54 |
Structural constituent of muscleCalcium ion bindingTelethonin bindingSarcomere organizationActin filament binding |
2.60.40.10 |
97 |
16 |
76 |
2.25 |
2.94 |
 |
1ypzF01 |
84.32 |
|
2.60.40.10 |
123 |
22 |
84 |
2.76 |
3.26 |
 |
3k3qA00 |
84.14 |
|
2.60.40.10 |
137 |
29 |
77 |
1.85 |
2.39 |
 |
2qsqB01 |
83.97 |
Carcinoembryonic antigen-related cell adhesion molecule 5Integral to plasma membraneHomo sapiensBasolateral plasma membrane |
2.60.40.10 |
108 |
12 |
89 |
3.44 |
3.83 |
 |
2j8hA01 |
83.92 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
97 |
14 |
77 |
2.63 |
3.40 |
 |
1f97A01 |
83.91 |
Mus musculusEpithelial cell differentiationJunctional adhesion molecule ACell adhesionTight junction |
2.60.40.10 |
102 |
17 |
84 |
2.74 |
3.23 |
 |
2rikA02 |
83.90 |
TitinOryctolagus cuniculus |
2.60.40.10 |
95 |
16 |
75 |
2.42 |
3.21 |
 |
2rikA03 |
83.83 |
TitinOryctolagus cuniculus |
2.60.40.10 |
92 |
16 |
75 |
2.40 |
3.18 |
 |
1hkfA00 |
83.83 |
Integral to plasma membraneNatural cytotoxicity triggering receptor 2Cellular defense responseNatural killer cell mediated cytotoxicitySignal transduction |
2.60.40.10 |
108 |
10 |
92 |
3.50 |
3.78 |
 |
1fo0B00 |
83.82 |
|
2.60.40.10 |
112 |
17 |
89 |
2.92 |
3.27 |
 |
2ny1B01 |
83.78 |
Zinc ion bindingMaintenance of protein location in cellT-cell surface glycoprotein CD4Signal transductionT cell receptor signaling pathway |
2.60.40.10 |
98 |
16 |
83 |
2.64 |
3.18 |
 |
2rikA01 |
83.30 |
TitinOryctolagus cuniculus |
2.60.40.10 |
96 |
17 |
75 |
2.28 |
3.02 |
 |
1xauA00 |
83.29 |
Integral to plasma membraneReceptor activityNegative regulation of B cell proliferationProtein bindingMus musculus |
2.60.40.10 |
104 |
9 |
82 |
2.51 |
3.06 |
 |
1fhgA00 |
83.27 |
TelokinMeleagris gallopavo |
2.60.40.10 |
102 |
14 |
76 |
2.55 |
3.34 |
 |
1dr9A01 |
83.19 |
Type I diabetes mellitusAutoimmune thyroid diseaseIntestinal immune network for IgA productionAllograft rejectionT-lymphocyte activation antigen CD80 |
2.60.40.10 |
105 |
12 |
87 |
3.96 |
4.51 |
 |
1qfoC00 |
83.14 |
Mus musculusSialoadhesinProtein binding |
2.60.40.10 |
114 |
16 |
89 |
4.37 |
4.88 |
 |
1g1cA00 |
83.10 |
Structural constituent of muscleCalcium ion bindingTelethonin bindingSarcomere organizationActin filament binding |
2.60.40.10 |
98 |
10 |
76 |
2.45 |
3.21 |
 |
2j8hA02 |
82.96 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
98 |
12 |
75 |
2.74 |
3.63 |
 |
2a38B01 |
82.84 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
99 |
11 |
77 |
2.56 |
3.31 |
 |
1cczA01 |
82.81 |
Homo sapiensLymphocyte function-associated antigen 3Protein binding |
2.60.40.10 |
93 |
13 |
82 |
3.89 |
4.74 |
 |
1qz1A03 |
82.80 |
Rattus norvegicusPrion diseasesNeural cell adhesion moleculePlasma membraneFibroblast growth factor receptor binding |
2.60.40.10 |
95 |
17 |
75 |
2.78 |
3.68 |
 |
1iilG02 |
82.76 |
Cell surfacePathways in cancerNucleusPositive regulation of cell proliferationFibroblast growth factor binding |
2.60.40.10 |
107 |
13 |
77 |
3.43 |
4.42 |
 |
2dm2A00 |
82.43 |
NucleusHomo sapiensPalladinActin filamentMuscle alpha-actinin binding |
2.60.40.10 |
110 |
12 |
74 |
3.00 |
4.02 |
 |
1waaC00 |
82.42 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
93 |
6 |
70 |
1.79 |
2.53 |
 |
1ncnA00 |
82.41 |
T-lymphocyte activation antigen CD86Positive regulation of cell proliferationHomo sapiensImmune responseProtein binding |
2.60.40.10 |
110 |
14 |
84 |
2.95 |
3.49 |
 |
1f3rB02 |
82.37 |
|
2.60.40.10 |
99 |
18 |
75 |
1.87 |
2.48 |
 |
1pkoA00 |
82.33 |
Rattus norvegicusMyelin-oligodendrocyte glycoproteinPositive regulation of MyD88-dependent toll-like receptor signaling pathway |
2.60.40.10 |
123 |
10 |
78 |
2.52 |
3.23 |
 |
1eajB00 |
82.02 |
Integral to plasma membraneReceptor activityCoxsackievirus and adenovirus receptorViral myocarditisCoxsackievirus and adenovirus receptor |
2.60.40.10 |
120 |
13 |
84 |
3.33 |
3.96 |
 |
1i1rA01 |
81.90 |
Jak-STAT signaling pathwayOncostatin-M receptor complexResponse to cytokine stimulusPositive regulation of osteoblast differentiationPositive regulation of tyrosine phosphorylation of Stat1 protein |
2.60.40.10 |
100 |
7 |
75 |
2.43 |
3.22 |
 |
3cafA01 |
81.87 |
Cell surfacePathways in cancerNucleusPositive regulation of cell proliferationFibroblast growth factor binding |
2.60.40.10 |
96 |
13 |
76 |
3.09 |
4.04 |
 |
2g5rA00 |
81.77 |
Sialic acid-binding Ig-like lectin 7Sialic acid binding Ig-like lectin 7Receptor activityIntegral to plasma membraneHomo sapiens |
2.60.40.10 |
113 |
11 |
84 |
3.63 |
4.27 |
 |
1gl4B00 |
81.76 |
Chondrocyte differentiationCardiac muscle tissue developmentCartilage development involved in endochondral bone morphogenesisProtein localizationBrain development |
2.60.40.10 |
89 |
14 |
71 |
2.47 |
3.44 |
 |
1dqtA00 |
81.61 |
Mus musculusExternal side of plasma membraneCytotoxic T-lymphocyte protein 4 |
2.60.40.10 |
117 |
11 |
85 |
3.68 |
4.31 |
 |
2c5dC01 |
81.60 |
Integral to plasma membraneTransmembrane receptor protein tyrosine kinase activityHomo sapiensTyrosine-protein kinase receptor UFOSignal transduction |
2.60.40.10 |
104 |
10 |
75 |
2.17 |
2.88 |
 |
1koaA03 |
81.59 |
Caenorhabditis elegansProtein ZK617.1b, partially confirmed by transcript evidenceLocomotionReproduction |
2.60.40.10 |
96 |
10 |
74 |
2.31 |
3.10 |
 |
1olzA03 |
81.52 |
Anti-apoptosisReceptor bindingSemaphorin-4DReceptor activityCell adhesion |
2.60.40.10 |
89 |
14 |
73 |
3.42 |
4.65 |
 |
3b43A02 |
81.40 |
TitinOryctolagus cuniculus |
2.60.40.10 |
97 |
13 |
75 |
2.47 |
3.27 |
 |
1bihA04 |
81.19 |
Hyalophora cecropiaHemolin |
2.60.40.10 |
88 |
19 |
70 |
2.83 |
4.00 |
 |
2ec8A03 |
81.14 |
Pathways in cancerHematopoietic cell lineageProto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]Acute myeloid leukemiaProtein binding |
2.60.40.10 |
104 |
13 |
74 |
2.98 |
4.00 |
 |
1uctA01 |
81.03 |
Immunoglobulin alpha Fc receptorIntegral to plasma membraneCD89 antigenHomo sapiensImmune response |
2.60.40.10 |
91 |
10 |
72 |
2.57 |
3.54 |
 |
1nkrA01 |
81.00 |
Integral to plasma membraneReceptor activityHomo sapiensNatural killer cell inhibitory signaling pathwayImmune response |
2.60.40.10 |
97 |
14 |
76 |
2.42 |
3.17 |
 |
1l6zA02 |
80.89 |
Mus musculusCarcinoembryonic antigen-related cell adhesion molecule 1 |
2.60.40.10 |
96 |
12 |
72 |
2.37 |
3.26 |
 |
1vcaA01 |
80.83 |
Vascular cell adhesion protein 1MicrovillusPositive regulation of T cell proliferationHeterophilic cell-cell adhesionFilopodium |
2.60.40.10 |
89 |
15 |
72 |
2.73 |
3.76 |
 |
2cqvA00 |
80.75 |
Myosin light chain kinase activityProtein phosphorylationHomo sapiensMyosin light chain kinase, smooth muscle |
2.60.40.10 |
114 |
11 |
70 |
2.56 |
3.65 |
 |
2ec8A04 |
80.64 |
Pathways in cancerHematopoietic cell lineageProto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]Extracellular spaceAcute myeloid leukemia |
2.60.40.10 |
100 |
8 |
74 |
2.71 |
3.64 |
 |
1f97A02 |
80.61 |
Mus musculusEpithelial cell differentiationJunctional adhesion molecule ACell adhesionTight junction |
2.60.40.10 |
105 |
13 |
80 |
3.30 |
4.12 |
 |
2gy5A02 |
80.53 |
Cell surfaceMicrovillusTransmembrane receptor protein tyrosine kinase signaling pathwayProtein bindingSignal transduction |
2.60.40.10 |
90 |
14 |
68 |
2.03 |
2.95 |
 |
1cs6A04 |
80.51 |
Cell adhesion molecule bindingContactin 2Neuron cell-cell adhesionGallus gallusContactin-2 |
2.60.40.10 |
90 |
14 |
71 |
2.61 |
3.64 |
 |
1zxqA02 |
80.50 |
Intercellular adhesion molecule 2Integral to plasma membraneIntercellular adhesion molecule 2Natural killer cell mediated cytotoxicityHomo sapiens |
2.60.40.10 |
107 |
13 |
80 |
3.71 |
4.62 |
 |
1gsmA01 |
80.49 |
Membrane fractionMucosal vascular addressin cell adhesion molecule 1Intestinal immune network for IgA productionCell adhesionHomo sapiens |
2.60.40.10 |
90 |
12 |
71 |
3.38 |
4.71 |
 |
1cs6A02 |
80.37 |
Cell adhesion molecule bindingContactin 2Neuron cell-cell adhesionGallus gallusContactin-2 |
2.60.40.10 |
89 |
12 |
69 |
3.02 |
4.33 |
 |
1itbB03 |
80.07 |
Platelet-derived growth factor receptor bindingIntegral to plasma membraneHematopoietic cell lineageInterleukin 1 receptor, type IInterleukin-1-mediated signaling pathway |
2.60.40.10 |
112 |
9 |
74 |
2.68 |
3.62 |
 |
1cs6A03 |
80.07 |
Cell adhesion molecule bindingContactin 2Neuron cell-cell adhesionGallus gallusContactin-2 |
2.60.40.10 |
98 |
12 |
73 |
2.91 |
3.95 |
 |
1nkrA02 |
79.95 |
Receptor activityIntegral to plasma membraneHomo sapiensImmune responseNatural killer cell inhibitory signaling pathway |
2.60.40.10 |
98 |
14 |
73 |
2.19 |
2.98 |
 |
1iamA02 |
79.91 |
Leukocyte migrationAdhesion to symbiontHeterophilic cell-cell adhesionRegulation of leukocyte mediated cytotoxicityT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
2.60.40.10 |
102 |
8 |
76 |
2.85 |
3.73 |
 |
1cs6A01 |
79.83 |
Cell adhesion molecule bindingContactin 2Neuron cell-cell adhesionGallus gallusContactin-2 |
2.60.40.10 |
105 |
11 |
79 |
3.26 |
4.11 |
 |
1witA00 |
79.82 |
Caenorhabditis elegansProtein ZK617.1b, partially confirmed by transcript evidenceLocomotionReproduction |
2.60.40.10 |
93 |
15 |
75 |
3.14 |
4.16 |
 |
1bihA03 |
79.82 |
Hyalophora cecropiaHemolin |
2.60.40.10 |
100 |
13 |
75 |
3.74 |
4.96 |
 |
2fcbA02 |
79.68 |
Low affinity immunoglobulin gamma Fc region receptor II-bHomo sapiensImmune responseSignal transduction |
2.60.40.10 |
87 |
9 |
68 |
2.93 |
4.25 |
 |
1pd6A00 |
79.21 |
Myosin-binding protein C, cardiac-typeHomo sapiensVentricular cardiac muscle tissue morphogenesisStriated muscle myosin thick filamentStructural constituent of muscle |
2.60.40.10 |
94 |
11 |
71 |
2.64 |
3.68 |
 |
1bihA01 |
79.12 |
Hyalophora cecropiaHemolin |
2.60.40.10 |
97 |
11 |
75 |
2.86 |
3.79 |
 |
1fltX00 |
79.11 |
Vascular endothelial growth factor receptor 1Integral to plasma membraneGrowth factor bindingVascular endothelial growth factor receptor activityFemale pregnancy |
2.60.40.10 |
95 |
8 |
73 |
3.35 |
4.55 |
 |
1p53A01 |
78.88 |
Leukocyte migrationAdhesion to symbiontHeterophilic cell-cell adhesionRegulation of leukocyte mediated cytotoxicityT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
2.60.40.10 |
98 |
12 |
72 |
2.72 |
3.74 |
 |
1t0pB00 |
78.81 |
Integral to plasma membraneIntercellular adhesion molecule 3Homo sapiensIntercellular adhesion molecule 3Cell adhesion molecules (CAMs) |
2.60.40.10 |
86 |
11 |
66 |
2.91 |
4.34 |
 |
2gy5A04 |
78.75 |
MicrovillusCell surfaceTransmembrane receptor protein tyrosine kinase signaling pathwaySignal transductionProtein binding |
2.60.40.10 |
99 |
14 |
74 |
3.12 |
4.19 |
 |
2v44A02 |
78.74 |
Prion diseasesNeural cell adhesion moleculePlasma membraneNeuron cell-cell adhesionNeural cell adhesion molecule 2 |
2.60.40.10 |
93 |
12 |
74 |
3.52 |
4.72 |
 |
1cidA01 |
78.70 |
Rattus norvegicusT-cell surface glycoprotein CD4Hematopoietic cell lineageT cell receptor signaling pathwayAntigen processing and presentation |
2.60.40.10 |
106 |
7 |
89 |
3.99 |
4.45 |
 |
1f2qA02 |
78.69 |
High affinity immunoglobulin epsilon receptor subunit alphaIntegral to plasma membraneHomo sapiensFc receptor, IgE, high affinity I, alpha polypeptideAsthma |
2.60.40.10 |
90 |
16 |
68 |
3.16 |
4.59 |
 |
1o0vA01 |
78.68 |
Homo sapiensIg epsilon chain C region |
2.60.40.10 |
102 |
11 |
76 |
3.62 |
4.74 |
 |
1q0xL02 |
78.57 |
Mus musculusIg lambda-1 chain V regionProtein binding |
2.60.40.10 |
100 |
9 |
75 |
3.26 |
4.32 |
 |
1rhfA02 |
78.35 |
Integral to plasma membraneTyrosine-protein kinase receptor TYRO3Cell adhesionTYRO3 protein tyrosine kinase 3 [EC:2.7.10.1]Signal transduction |
2.60.40.10 |
84 |
16 |
66 |
2.73 |
4.08 |
 |
2e9wA01 |
78.20 |
Pathways in cancerHematopoietic cell lineageProto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]Acute myeloid leukemiaExtracellular space |
2.60.40.10 |
84 |
8 |
61 |
2.47 |
4.03 |
 |
2ec8A01 |
78.19 |
Pathways in cancerHematopoietic cell lineageProto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]Acute myeloid leukemiaProtein binding |
2.60.40.10 |
92 |
7 |
61 |
2.74 |
4.47 |
 |
3bfoA00 |
78.12 |
T cell receptor signaling pathwayPositive regulation of T cell cytokine productionActivation of NF-kappaB-inducing kinase activityPositive regulation of interleukin-2 productionNucleus |
2.60.40.10 |
85 |
8 |
65 |
3.17 |
4.87 |
 |
1xiwA00 |
78.05 |
Chagas diseaseHematopoietic cell lineageReceptor signaling protein activitySH3 domain bindingT cell receptor signaling pathway |
2.60.40.10 |
91 |
13 |
69 |
3.10 |
4.44 |
 |
1nctA00 |
77.77 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
98 |
14 |
75 |
3.03 |
4.01 |
 |
2gy5A01 |
77.62 |
Cell surfaceMicrovillusIntegral to plasma membraneTransmembrane receptor protein tyrosine kinase signaling pathwaySignal transduction |
2.60.40.10 |
99 |
10 |
77 |
3.71 |
4.80 |
 |
1edqA01 |
77.55 |
Chitinase ASerratia marcescens |
2.60.40.10 |
107 |
4 |
69 |
2.62 |
3.79 |
 |
1dn0D02 |
77.48 |
|
2.60.40.10 |
94 |
11 |
69 |
3.39 |
4.86 |
 |
1gsmA02 |
77.43 |
Membrane fractionMucosal vascular addressin cell adhesion molecule 1Intestinal immune network for IgA productionCell adhesionHomo sapiens |
2.60.40.10 |
116 |
8 |
69 |
2.97 |
4.25 |
 |
3b4nA01 |
77.37 |
Erwinia chrysanthemiEndo-pectate lyase |
2.60.40.10 |
88 |
4 |
71 |
3.10 |
4.32 |
 |
1bihA02 |
77.21 |
Hyalophora cecropiaHemolin |
2.60.40.10 |
106 |
12 |
79 |
3.78 |
4.77 |
 |
1ej6A05 |
77.20 |
Mammalian orthoreovirus 3 DearingOuter capsid protein lambda-2 |
2.60.40.10 |
95 |
11 |
78 |
3.47 |
4.43 |
 |
2nqcA00 |
77.18 |
Plasma membraneFilamin-CHomo sapiens |
2.60.40.10 |
97 |
7 |
69 |
3.40 |
4.87 |
 |
1cczA02 |
77.09 |
Homo sapiensLymphocyte function-associated antigen 3Protein binding |
2.60.40.10 |
78 |
7 |
60 |
2.92 |
4.84 |
 |
2r2cB00 |
77.00 |
Porphyromonas gingivalis28 kDa outer membrane protein Omp28 |
2.60.40.320 |
107 |
1 |
76 |
3.74 |
4.88 |
 |
2fcbA01 |
76.91 |
Low affinity immunoglobulin gamma Fc region receptor II-bHomo sapiensImmune responseSignal transduction |
2.60.40.10 |
86 |
12 |
64 |
3.20 |
4.99 |
 |
1axiB02 |
76.74 |
Jak-STAT signaling pathwayCell surfaceMulticellular organismal metabolic processGrowth hormone receptor complexInsulin-like growth factor receptor signaling pathway |
2.60.40.10 |
101 |
5 |
76 |
3.79 |
4.96 |
 |
1cwvA02 |
76.54 |
InvasinYersinia pseudotuberculosis |
2.60.40.920 |
97 |
6 |
70 |
3.05 |
4.31 |
 |
2gysA03 |
76.32 |
Jak-STAT signaling pathwayGranulocyte macrophage colony-stimulating factor receptor complexCytokine receptor common subunit betaCytokine receptor common subunit betaApoptosis |
2.60.40.10 |
86 |
6 |
70 |
3.13 |
4.42 |
 |
3b9eA01 |
76.08 |
Vibrio harveyiChitinase A |
2.60.40.10 |
110 |
3 |
68 |
2.69 |
3.95 |
 |
3cmgA04 |
75.79 |
Putative beta-galactosidaseBacteroides fragilis NCTC 9343 |
2.60.40.1560 |
87 |
9 |
67 |
3.28 |
4.83 |
 |
1f00I01 |
75.63 |
Pathogenic Escherichia coli infectionIntiminIntiminProtein bindingEscherichia coli O127:H6 str. E2348/69 |
2.60.40.920 |
95 |
7 |
71 |
3.27 |
4.56 |
 |
1cidA02 |
75.36 |
Rattus norvegicusT-cell surface glycoprotein CD4Hematopoietic cell lineageT cell receptor signaling pathwayAntigen processing and presentation |
2.60.40.10 |
71 |
12 |
62 |
2.84 |
4.56 |
 |
1g0dA01 |
75.18 |
Protein-glutamine gamma-glutamyltransferase 2Pagrus major |
2.60.40.10 |
137 |
8 |
69 |
3.40 |
4.90 |
 |
1tdqA02 |
75.10 |
Nervous system developmentRattus norvegicusTenascinFocal adhesionProteinaceous extracellular matrix |
2.60.40.10 |
90 |
7 |
74 |
3.24 |
4.35 |
 |
2ny1B02 |
74.77 |
Zinc ion bindingMaintenance of protein location in cellT-cell surface glycoprotein CD4Signal transductionT cell receptor signaling pathway |
2.60.40.10 |
75 |
13 |
65 |
3.01 |
4.62 |
 |
1u2cA01 |
74.77 |
Epithelial tube branching involved in lung morphogenesisDilated cardiomyopathyECM-receptor interactionHypertrophic cardiomyopathy (HCM)Sarcolemma |
2.60.40.10 |
103 |
6 |
77 |
3.50 |
4.52 |
 |
1fnfA02 |
74.48 |
FibronectinPeptide cross-linkingER-Golgi intermediate compartmentFibrinogen complexSubstrate adhesion-dependent cell spreading |
2.60.40.10 |
87 |
6 |
72 |
3.11 |
4.28 |
 |
1ujtA00 |
74.46 |
LuteolysisPositive regulation of axonogenesisCell surfaceIdentical protein bindingHomophilic cell adhesion |
2.60.40.10 |
120 |
3 |
66 |
3.32 |
4.98 |
 |
1j8kA00 |
74.13 |
FibronectinPeptide cross-linkingER-Golgi intermediate compartmentFibrinogen complexSubstrate adhesion-dependent cell spreading |
2.60.40.10 |
94 |
10 |
74 |
3.58 |
4.80 |
 |
1qg3A01 |
73.94 |
Homo sapiensIntegrin beta-4Protein bindingIntegrin complex |
2.60.40.10 |
91 |
4 |
70 |
3.23 |
4.57 |
 |
1qr4A01 |
73.66 |
TenascinGallus gallus |
2.60.40.10 |
87 |
4 |
72 |
3.02 |
4.16 |